Rethinking therapeutic and recreational nicotine products: A commentary on Hatsukami et al

Tobacco Control

Volumn 25, Issue 3, 2016, Pages 245-

  Borland, Ron ^a   Gartner, Coral ^b  

^a CANCER EPIDEMIOLOGY CENTRE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINE GUM;

HARM REDUCTION; HUMAN; SMOKING; SMOKING CESSATION;

HARM REDUCTION; HUMANS; NICOTINE; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS;

EID: 84964239477     PISSN: 09644563     EISSN: 14683318     Source Type: Journal    
DOI: 10.1136/tobaccocontrol-2015-052388     Document Type: Editorial

References (6)

1. Hatsukami D, Severson H, Anderson A, et al. Randomized clinical trial of snus vs. medicinal nicotine among smokers interested in product switching. Tob Control 2016;25:267-74.
2. West R, Beard E, Brown J. Trends in electronic cigarette use in England STS140122; University College London 23/04/2015. http://www.smokinginengland.info/latest-statistics
3. Borland R. Understanding hard to maintain behaviour change: a dual-process approach. Oxford: Blackwell-Wiley, 2014.
4. Gu X, Lohrenz T, Salas R, et al. Belief about nicotine selectively modulates value and reward prediction error signals in smokers. Proc Natl Acad Sci USA 2015; 112:2539-44.
5. Frankel T. The mysterious nicotine lozenge that ex-smokers are hoarding. The Washington Post 9 Feb 2015. http://www.washingtonpost.com/busin7ess/economy/the-mysterious-nicotine-lozenge-that-exsmokers-are-hoarding/2015/02/09/2b8d19c6-ae37-11e4-abe8-e1ef60ca26de_story.html
6. Gartner CE, Hall WD, McNeill A. Chapter 9: harm reduction policies for tobacco. In: Rhodes T, Hedrich D, eds. Harm reduction: evidence, impacts and challenges. Lisbon: EMCDDA, 2010: 255-73.